Karen Noblett - 26 Dec 2023 Form 4 Insider Report for Axonics, Inc.

Signature
Kari L. Keese, as Attorney-in-fact for Karen Noblett
Issuer symbol
N/A
Transactions as of
26 Dec 2023
Net transactions value
-$505,964
Form type
4
Filing time
28 Dec 2023, 19:17:00 UTC
Previous filing
02 Feb 2023
Next filing
10 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Sale $59,787 -949 -2.2% $63.00 41,266 26 Dec 2023 Direct F1
transaction AXNX Common Stock Sale $446,177 -7,051 -17% $63.28 34,215 28 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan entered into on September 15, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $63.00 to $63.8425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.